These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Specific allergy immunotherapy for allergic rhinitis: subcutaneous and sublingual.
    Author: Cox L, Wallace D.
    Journal: Immunol Allergy Clin North Am; 2011 Aug; 31(3):561-99. PubMed ID: 21737043.
    Abstract:
    Numerous controlled clinical trials have demonstrated the efficacy of specific allergen immunotherapy (SIT) in reducing the clinical symptoms and costs associated with allergic rhinitis. Compared with pharmacotherapy, SIT may provide persistent clinical benefits after treatment discontinuation. Subcutaneous and sublingual immunotherapy are the two most widely prescribed SIT routes worldwide. This review compares the efficacy, safety, preventive effect, immunologic mechanisms, and adherence rates associated with these two forms of SIT.
    [Abstract] [Full Text] [Related] [New Search]